查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2016402

人類絨毛膜促性腺激素分泌市場報告：按技術、治療領域、最終用戶和地區分類（2026-2034 年）

Human Chorionic Gonadotropin Market Report by Technology, Therapeutic Area, End User, and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 135 Pages | 商品交期: 2-3個工作天內

價格

2025年，全球人類絨毛膜促性腺激素分泌（HCG）市場規模達11.038億美元。展望未來，IMARC Group預測，到2034年，市場規模將達到19.059億美元，2026年至2034年的複合年成長率（CAGR）為6.07%。女性不孕症發生率上升、性腺功能減退相關疾病盛行率增加、採用重組技術生產HCG是推動市場成長的主要因素。

人類絨毛膜促性腺激素分泌(HCG) 是懷孕期間由胎盤合體滋養層細胞產生的化學物質。它存在於血液、尿液、肝臟、結腸和腦下垂體。 HCG 刺激層析法、染料親和性和層析法、奈米過濾和反相高效液相層析(HPLC)。 HCG 廣泛用於治療不孕症、提高受孕幾率、促進睪固酮和精子生成以及治療男嬰隱睪。它還可用於診斷和後續觀察妊娠相關疾病、產前篩檢以及婦科癌症的診斷。

人類絨毛膜促性腺激素分泌（HCG）市場趨勢：

子宮疾病、輸卵管阻塞、卵巢症候群（PCOS）和內分泌失調導致女性不孕症的發生率不斷上升，是推動市場成長的主要因素之一。 HCG廣泛應用於各種輔助生殖技術，例如體外受精（IVF）和子宮內人工授精（IUI），用於治療女性不孕症，因為它有助於誘導排卵、促進胚胎發育、確保最佳卵子時機、增加子宮內膜厚度並提高子宮內膜容受性。此外，該產品與其他不孕症治療方法合併使用，以提高女性的懷孕幾率，也是推動市場成長的另一個因素。此外，肥胖和第2型糖尿病男性中性腺功能減退相關疾病的盛行率不斷上升，導致HCG的使用量增加，以提高睪固酮水平、增強生育能力和改善性功能，這也促進了市場成長。此外，以重組技術生產的HCG與天然HCG具有相同的特性，且療效更佳、安全性更高，並能提高患者的耐受性，這正積極推動市場成長。其他預計將進一步促進市場成長的因素包括：醫療基礎設施的快速發展、生育治療及相關服務的普及、老年人口的成長、旨在引入新型純化和提取技術的廣泛研發活動，以及政府為改善民眾性健康而採取的各項措施。

本報告解答的主要問題

  • 迄今為止，全球人類絨毛膜促性腺激素分泌(HCG) 市場的發展趨勢是什麼？您預計未來幾年這些趨勢將如何發展？
  • 全球人類絨毛膜促性腺激素分泌(HCG) 市場的市場促進因素、阻礙因素和機會是什麼？
  • 主要區域市場有哪些？
  • 在人類絨毛膜促性腺激素分泌（HCG）市場中，哪個國家最具吸引力？
  • 市場按技術分類是怎樣的？
  • 按治療區域分類的市場組成是什麼？
  • 依最終用戶分類的市場區隔如何？
  • 全球人類絨毛膜促性腺激素分泌（HCG）市場的競爭格局如何？
  • 全球人類絨毛膜促性腺激素分泌(HCG) 市場的主要參與者/公司有哪些？

目錄

第1章：序言

第2章：調查方法

  • 調查目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 次要訊息
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章執行摘要

第4章：引言

第5章：全球人類絨毛膜促性腺激素分泌市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場預測

第6章 市場區隔：依技術分類

  • 從自然資源中提取資源
  • 重組技術

第7章 市場區隔：依治療領域分類

  • 女性不孕症治療
  • 男性性腺功能低下症
  • 少精症治療
  • 其他

第8章 市場區隔：依最終用戶分類

  • 不孕症治療診所
  • 研究機構
  • 其他

第9章 市場區隔：依地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第10章：促進、抑制與機遇

第11章：價值鏈分析

第12章：波特五力分析

第13章：價格分析

第14章 競爭格局

  • 市場結構
  • 主要企業
  • 主要企業簡介
    • Biocare Medical LLC
    • Ferring Pharmaceuticals
    • Fresenius SE & Co. KGaA
    • Kamiya Biomedical Company（Nitto Boseki Co. Ltd.）
    • Lee Biosolutions Inc.（Oy Medix Biochemica Ab）
    • Merck & Co. Inc.
    • Prospec-Tany Technogene Ltd.
    • Scripps Laboratories Inc.
    • Sun Pharmaceutical Industries Limited
Product Code: SR112026A7059

The global human chorionic gonadotropin (HCG) market size reached USD 1,103.8 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 1,905.9 Million by 2034, exhibiting a growth rate (CAGR) of 6.07% during 2026-2034. The rising incidences of infertility in women, increasing prevalence of hypogonadism-related disorders, and production of HCG using recombinant technology represent some of the key factors driving the market.

Human chorionic gonadotropin (HCG) is a chemical produced by syncytiotrophoblastic cells of the placenta during pregnancy. It is found in blood, urine, liver, colon, and pituitary glands. HCG stimulates the corpus luteum to produce progesterone to maintain the pregnancy. It is extracted and purified from the urine of pregnant women for clinical applications using various techniques, such as ion exchange chromatography, dye-affinity chromatography, nanofiltration, and reverse-phase high-performance liquid chromatography (HPLC). HCG is widely used to treat infertility, increase the chances of pregnancy, help in the production of testosterone and sperm, and treat cryptorchidism in male children. It also aids in diagnosing and monitoring pregnancy-related disorders, prenatal screening, and gynecological cancers.

HUMAN CHORIONIC GONADOTROPIN (HCG) MARKET TRENDS:

The rising incidences of infertility among females due to uterine disorders, blocked fallopian tube, polycystic ovarian syndrome (PCOS), and endocrine system disorders are among the key factors driving the market growth. HCG is widely used in various assisted reproductive technologies, such as in-vitro fertilization (IVF) and intrauterine insemination (IUI), to treat female infertility, as it aids in inducing ovulation, promotes the formation of the embryo, facilitates correct timing of oocyte retrieval, increases endometrial thickness, and improve endometrial receptivity. In addition to this, the widespread product utilization in combination with other fertility drugs to increase the chances of pregnancy in women is acting as another growth-inducing factor. Furthermore, the increasing application of HCG to improve testosterone levels, enhance fertility, and promote sexual function due to the increasing prevalence of hypogonadism-related disorders in males suffering from obesity and type 2 diabetes is favoring the market growth. Additionally, the production of HCG using recombinant technology that provides identical properties, enhanced efficacy, and improved safety compared to naturally sourced HCG and enhances patient tolerance is positively influencing the market growth. Other factors, including the rapid development of healthcare infrastructure, increasing availability of treatment and services regarding infertility, rising geriatric population, extensive research and development (R&D) activities for the launch of novel purification and extraction technologies, and the implementation of various government initiatives to improve the sexual health of people, are anticipated to drive the market growth further.

KEY MARKET SEGMENTATION:

Technology Insights:

  • Natural Source Extraction
  • Recombinant Technology

The report has also provided a detailed breakup and analysis of the human chorionic gonadotropin (HCG) market based on the technology. This includes natural source extraction and recombinant technology. According to the report, natural source extraction represented the largest segment.

Therapeutic Area Insights:

  • Female Infertility Treatment
  • Male Hypogonadism
  • Oligospermic Treatment
  • Others

End User Insights:

  • Fertility Clinics
  • Research Institutions
  • Others

Regional Insights:

  • North America
    • United States
    • Canada
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and Middle East and Africa. According to the report, North America was the largest market for human chorionic gonadotropin (HCG). Some of the factors driving the North America human chorionic gonadotropin (HCG) market include rising incidences of infertility among women, growing consumer awareness regarding the available treatment for infertility and gynecological concerns, and rising expenditure capacities of consumers.

COMPETITIVE LANDSCAPE:

The report has also provided a comprehensive analysis of the competitive landscape in the global human chorionic gonadotropin (HCG) market. Detailed profiles of all major companies have also been provided. Some of the companies covered include Biocare Medical LLC, Ferring Pharmaceuticals, Fresenius SE & Co. KGaA, Kamiya Biomedical Company (Nitto Boseki Co. Ltd.), Lee Biosolutions Inc. (Oy Medix Biochemica Ab), Merck & Co. Inc., Prospec-Tany Technogene Ltd., Scripps Laboratories Inc., Sun Pharmaceutical Industries Limited, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

KEY QUESTIONS ANSWERED IN THIS REPORT

  • How has the global human chorionic gonadotropin (HCG) market performed so far and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global human chorionic gonadotropin (HCG) market?
  • What are the key regional markets?
  • Which countries represent the most attractive human chorionic gonadotropin (HCG) markets?
  • What is the breakup of the market based on the technology?
  • What is the breakup of the market based on the therapeutic area?
  • What is the breakup of the market based on the end user?
  • What is the competitive structure of the global human chorionic gonadotropin (HCG) market?
  • Who are the key players/companies in the global human chorionic gonadotropin (HCG) market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Human Chorionic Gonadotropin (HCG) Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Technology

  • 6.1 Natural Source Extraction
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Recombinant Technology
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Therapeutic Area

  • 7.1 Female Infertility Treatment
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Male Hypogonadism
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Oligospermic Treatment
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Fertility Clinics
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Research Institutions
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 Drivers, Restraints, and Opportunities

  • 10.1 Overview
  • 10.2 Drivers
  • 10.3 Restraints
  • 10.4 Opportunities

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Biocare Medical LLC
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 Ferring Pharmaceuticals
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Fresenius SE & Co. KGaA
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Kamiya Biomedical Company (Nitto Boseki Co. Ltd.)
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 Lee Biosolutions Inc. (Oy Medix Biochemica Ab)
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 Merck & Co. Inc.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Prospec-Tany Technogene Ltd.
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 Scripps Laboratories Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 Sun Pharmaceutical Industries Limited
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Human Chorionic Gonadotropin Market: Major Drivers and Challenges
  • Figure 2: Global: Human Chorionic Gonadotropin Market: Sales Value (in Million USD), 2020-2025
  • Figure 3: Global: Human Chorionic Gonadotropin Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 4: Global: Human Chorionic Gonadotropin Market: Breakup by Technology (in %), 2025
  • Figure 5: Global: Human Chorionic Gonadotropin Market: Breakup by Therapeutic Area (in %), 2025
  • Figure 6: Global: Human Chorionic Gonadotropin Market: Breakup by End User (in %), 2025
  • Figure 7: Global: Human Chorionic Gonadotropin Market: Breakup by Region (in %), 2025
  • Figure 8: Global: Human Chorionic Gonadotropin (Natural Source Extraction) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 9: Global: Human Chorionic Gonadotropin (Natural Source Extraction) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 10: Global: Human Chorionic Gonadotropin (Recombinant Technology) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 11: Global: Human Chorionic Gonadotropin (Recombinant Technology) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 12: Global: Human Chorionic Gonadotropin (Female Infertility Treatment) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 13: Global: Human Chorionic Gonadotropin (Female Infertility Treatment) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 14: Global: Human Chorionic Gonadotropin (Male Hypogonadism) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 15: Global: Human Chorionic Gonadotropin (Male Hypogonadism) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 16: Global: Human Chorionic Gonadotropin (Oligospermic Treatment) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 17: Global: Human Chorionic Gonadotropin (Oligospermic Treatment) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 18: Global: Human Chorionic Gonadotropin (Other Therapeutic Areas) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 19: Global: Human Chorionic Gonadotropin (Other Therapeutic Areas) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 20: Global: Human Chorionic Gonadotropin (Fertility Clinics) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 21: Global: Human Chorionic Gonadotropin (Fertility Clinics) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 22: Global: Human Chorionic Gonadotropin (Research Institutions) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 23: Global: Human Chorionic Gonadotropin (Research Institutions) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 24: Global: Human Chorionic Gonadotropin (Other End Users) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 25: Global: Human Chorionic Gonadotropin (Other End Users) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 26: North America: Human Chorionic Gonadotropin Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 27: North America: Human Chorionic Gonadotropin Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 28: United States: Human Chorionic Gonadotropin Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 29: United States: Human Chorionic Gonadotropin Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 30: Canada: Human Chorionic Gonadotropin Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 31: Canada: Human Chorionic Gonadotropin Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 32: Asia-Pacific: Human Chorionic Gonadotropin Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 33: Asia-Pacific: Human Chorionic Gonadotropin Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 34: China: Human Chorionic Gonadotropin Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 35: China: Human Chorionic Gonadotropin Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 36: Japan: Human Chorionic Gonadotropin Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 37: Japan: Human Chorionic Gonadotropin Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 38: India: Human Chorionic Gonadotropin Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 39: India: Human Chorionic Gonadotropin Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 40: South Korea: Human Chorionic Gonadotropin Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 41: South Korea: Human Chorionic Gonadotropin Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 42: Australia: Human Chorionic Gonadotropin Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 43: Australia: Human Chorionic Gonadotropin Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 44: Indonesia: Human Chorionic Gonadotropin Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 45: Indonesia: Human Chorionic Gonadotropin Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 46: Others: Human Chorionic Gonadotropin Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 47: Others: Human Chorionic Gonadotropin Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 48: Europe: Human Chorionic Gonadotropin Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 49: Europe: Human Chorionic Gonadotropin Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 50: Germany: Human Chorionic Gonadotropin Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 51: Germany: Human Chorionic Gonadotropin Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 52: France: Human Chorionic Gonadotropin Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 53: France: Human Chorionic Gonadotropin Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 54: United Kingdom: Human Chorionic Gonadotropin Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 55: United Kingdom: Human Chorionic Gonadotropin Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 56: Italy: Human Chorionic Gonadotropin Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 57: Italy: Human Chorionic Gonadotropin Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 58: Spain: Human Chorionic Gonadotropin Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 59: Spain: Human Chorionic Gonadotropin Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 60: Russia: Human Chorionic Gonadotropin Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 61: Russia: Human Chorionic Gonadotropin Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 62: Others: Human Chorionic Gonadotropin Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 63: Others: Human Chorionic Gonadotropin Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 64: Latin America: Human Chorionic Gonadotropin Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 65: Latin America: Human Chorionic Gonadotropin Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 66: Brazil: Human Chorionic Gonadotropin Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 67: Brazil: Human Chorionic Gonadotropin Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 68: Mexico: Human Chorionic Gonadotropin Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 69: Mexico: Human Chorionic Gonadotropin Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 70: Others: Human Chorionic Gonadotropin Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 71: Others: Human Chorionic Gonadotropin Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 72: Middle East and Africa: Human Chorionic Gonadotropin Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 73: Middle East and Africa: Human Chorionic Gonadotropin Market: Breakup by Country (in %), 2025
  • Figure 74: Middle East and Africa: Human Chorionic Gonadotropin Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 75: Global: Human Chorionic Gonadotropin Industry: Drivers, Restraints, and Opportunities
  • Figure 76: Global: Human Chorionic Gonadotropin Industry: Value Chain Analysis
  • Figure 77: Global: Human Chorionic Gonadotropin Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Human Chorionic Gonadotropin Market: Key Industry Highlights, 2025 & 2034
  • Table 2: Global: Human Chorionic Gonadotropin Market Forecast: Breakup by Technology (in Million USD), 2026-2034
  • Table 3: Global: Human Chorionic Gonadotropin Market Forecast: Breakup by Therapeutic Area (in Million USD), 2026-2034
  • Table 4: Global: Human Chorionic Gonadotropin Market Forecast: Breakup by End User (in Million USD), 2026-2034
  • Table 5: Global: Human Chorionic Gonadotropin Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 6: Global: Human Chorionic Gonadotropin Market: Competitive Structure
  • Table 7: Global: Human Chorionic Gonadotropin Market: Key Players